NewAmsterdam Pharma Co N.V Growth Metrics (2023-2025) | NAMS

Growth Metrics Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.62M0.05M0.15M0.54M0.54M0.16M-2.05M
EBITDA Margin (QoQ) -0.17M0.06M-0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.05M
EBIT Margin Growth (1y) -0.35M0.02M0.16M0.60M0.16M0.21M-1.58M
EBIT Margin (QoQ) -0.20M0.08M-0.47M0.24M0.17M0.22M-0.03M-0.20M0.21M-1.57M
EBT Margin Growth (1y) -0.62M0.05M0.15M0.54M0.54M0.16M-2.06M
EBT Margin (QoQ) -0.17M0.06M-0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.06M
Enterprise Value Growth (1y) 97.10%154.62%134.66%101.36%106.20%-11.69%-0.28%133.33%
Enterprise Value (QoQ) 68.93%-13.61%-3.78%40.36%118.23%-20.38%-17.43%43.73%-6.53%-10.10%93.21%
FCF Margin Growth (1y) -0.36M-0.07M0.16M0.38M0.27M0.22M-0.94M
FCF Margin (QoQ) -0.13M0.01M-0.25M0.02M0.15M0.23M-0.03M-0.09M0.10M-0.92M
Net Margin Growth (1y) -0.62M0.05M0.15M0.54M0.54M0.16M-2.06M
Net Margin (QoQ) -0.17M0.06M-0.46M-0.05M0.50M0.17M-0.07M-0.06M0.12M-2.06M
Operating Margin Growth (1y) -0.35M0.02M0.16M0.60M0.16M0.21M-1.58M
Operating Margin (QoQ) -0.20M0.08M-0.47M0.24M0.17M0.22M-0.03M-0.20M0.21M-1.57M
Return on Assets Growth (1y) 32.0029.0017.00
Return on Assets (QoQ) 6.004.008.0015.002.00-7.00
Return on Capital Employed Growth (1y) 32.0027.0019.00
Return on Capital Employed (QoQ) 6.004.0013.009.002.00-5.00
Return on Equity Growth (1y) 15.0041.0036.0023.00
Return on Equity (QoQ) -8.008.005.009.0018.003.00-8.00
Return on Sales Growth (1y) 725.000.00M0.00M-35.00
Return on Sales (QoQ) -0.00M243.000.00M62.00133.00139.00-368.00